Glucagon-like peptide-1 (7-36) amide: A central regulator of satiety and interoceptive stress

Neuropeptides

Volumn 33, Issue 5, 1999, Pages 406-414

  Dijk, G Van ^b   Thiele, T E ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON LIKE PEPTIDE 1 [7-36] AMIDE; PROTEIN INHIBITOR; RECEPTOR; TOXIN;

CENTRAL NERVOUS SYSTEM; FOOD INTAKE; GASTROINTESTINAL MOTILITY; HOMEOSTASIS; MALAISE; PRIORITY JOURNAL; PROTEIN PROCESSING; RECEPTOR BINDING; REVIEW; SATIETY; STRESS; TASTE AVERSION;

EID: 0032756657     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1054/npep.1999.0053     Document Type: Article

References (68)

1. Preuss H. G. Effects of glucose/insulin perturbations on aging and chronic disorders of aging: the evidence. J Am Coll Nutr. 16:1997;397-403.
2. Sowers J. R., Epstein M. Diabetes Mellitus and associated hypertension, vascular disease, and nephropathy. An update. Hypertension. 26:1995;869-879.
3. Woods S. C. The eating paradox: how we tolerate food. Psychol Rev. 98:1991;488-505.
4. Drucker D. J. Glucagon-like peptides. Diabetes. 47:1998;159-169.
5. Holst J. J. Glucagonlike peptide 1: a newly discovered gastrointestinal hormone. Gastroenterology. 107:1994;1848-1855.
6. van Dijk G., Lindskog S., Holst J. J., Steffens A. B., Ahrén B. Effects of glucagon-like peptide-1 on glucose turnover in rats. Am J Physiol. 270:1996;E1015-E1021.
7. Ahrén B., Lindskog S., van Dijk G., Scheurink A. J. W., Steffens A. B. Effects of GLP-1 and 2,5-anhydro-D-mannitol on insulin secretion and plasma glucose in mice. Endocr Res. 21:1995;583-594.
8. D'Alessio D. A., Kahn S. E., Leusner C. R., Ensinck J. W. Glucagon-like peptide 1 enhances glucose tolerance both by stimulation of insulin release and by increasing insulin-independent glucose disposal. J Clin Invest. 93:1994;2263-2266.
9. D'Alessio D. A., Vogel R., Prigeon R., Laschansky E., Koerker D., Eng J., Ensinck J. W. Elimination of the action of glucagon-like peptide 1 causes an impairment of glucose tolerance after nutrient ingestion by healthy baboons. J Clin Invest. 97:1996;133-138.
10. Scrocchi L. A., Brown T. J., MacClusky N., Brubaker P. L., Auerbach A. B., Joyner A. L., Drucker D. J. Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide 1 receptor gene. Nat Med. 2:1996;1254-1258.
11. Holst J. J., Deacon C. F. Inhibition of the activity of dipeptidyl-peptidase IV as a treatment for type 2 diabetes. Diabetes. 47:1998;1663-1670.
12. Wishart J. M., Horowitz M., Morris H. A., Jones K. L., Nauck M. A. Relation between gastric emptying and plasma concentrations of glucagon-like peptide-1. Peptides. 19:1998;1049-1053.
13. Nauck M. A., Niedereichholz U., Ettler R., Hoslt J. J., Orskov C., Ritzel R., Smiegel W. H. Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effect in healthy humans. Am J Physiol. 273:1997;E981-E988.
14. Wettergren A., Wojdmann M., Meisner S., Stadil F., Holst J. J. The inhibitory effect of glucagon-like peptide-1 (7-36) amide on gastric acid secretion in humans depends on an intact vagal innervation. Gut. 40:1997;697-701.
15. Wettergren A., Wojdmann M., Holst J. J. Glucagon-like peptide-1 inhibits gastropancreatic function by central parasympathetic outflow. Am J Physiol. 275:1998;G984-G992.
16. Giralt M., Vergara P. Sympathetic pathways mediate GLP-1 actions in the gastrointestinal tract of the rat. Regul Pept. 74:1998;19-25.
17. Flint A., Raben A., Astrup A., Holst J. J. Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans. J Clin Invest. 101:1998;515-520.
18. Naslund E., Barkeling B., King N., Gutniak M., Blundell J. E., Holst J. J., Hellstrom P. M. Energy intake and appetite are suppressed by glucagon-like peptide-1 (GLP-1) in obese men. Int J Obes Relat Metab Disord. 23:1999;304-311.
19. Gutzwiller J. P., Drewe J., Goke B., Schmidt H., Rohrer B., Lareida J., Beglinger C. Glucagon-like peptide-1 promotes satiety and reduces food intake in patients with diabetes mellitus type 2. Am J Physiol. 276:1999;1541-1544.
20. Han V. K. M., Hynes M. A., Jin C., Towle A. C., Lauder J. M., Lund P. K. Cellular localization of proglucagon/glucagon-like peptide 1 messenger RNAs in the rat brain. J Neurosc Res. 16:1986;97-107.
21. Jin S. L., Han V. K. M., Simmons J. G., Towle A. C., Lauder J. M., Lund P. K. Distribution of glucagon-like peptide 1, glucagon, and glicentin in the rat brain: an immunocytchemical study. J Comp Neurol. 271:1988;519-533.
22. Larsen P. J., Tang-Christensen M., Holst J. J., Orskov C. Distribution of glucagon-like peptide-1 and other preproglucagon-derived peptides in the rat hypothalamus and brainstem. Neuroscience. 77:1997;257-270.
23. Kreymann B., Ghatei M. A., Burnet P., Williams G., Kanse S., Diani A. R., Bloom S. R. Characterization of glucagon-like peptide-1-(7-36)amid in the hypothalamus. Brain Res. 502:1989;325-331.
24. Gøke R., Larsen P. J., Mikkelsen J. D., Sheikh S. P. Distribution of GLP-1 binding sites in the rats brain: evidence that exendin-4 is a ligand of brain GLP-1 binding sites. Eur J Neurosci. 7:1995;2294-2300.
25. Shimizu I., Hirota M., Ohboshi C., Shima K. Identification and localization of glucagon-like peptide-1 and its receptor in rat brain. Endocrinology. 121:1987;1076-1082.
26. Campos R. V., Lee Y. C., Drucker D. J. Divergent tissue-specific and developmental expression of receptors for glucagon and glucagon-like peptide-1 in the mouse. Endocrinology. 134:1994;2156-2164.
27. Imeryuz N., Yegen B. C., Bozkurt A., Coskun T., Villanueva-Penacarrillo M. L., Ulosyo N. B. Glucagon-like peptide-1 inhibits gastric emptying via vagal afferent-mediated central mechanisms. Am J Physiol. 273:1997;G920-G927.
28. Smith G. P., Gibbs J. The developent and proof of the cholecystokinin hypothesis of satiety. Dourish C. T., Cooper S. J., Iversen L. L. Multiple Cholecystokinin Receptors in the CNS. 1992;166-182 Oxford University Press; Oxford.
29. Ørskov C., Poulsen S. S., Møller M., Holst J. J. Glucagon-like peptide 1 receptors in the subfornical organ and the area postrema are accessible to circulating glucagon-like peptide 1. Diabetes. 45:1996;832-835.
30. Tang-Christensen M., Larsen P. J., Gøke R., Fink-Jensen A., Jessop D. S., Møller M., Sheikh S. P. Central administration of GLP-1-(7-36) amide inhibits food and water intake in rats. Am J Physiol. 271:1996;R848-R856.
31. Turton M. D., O'Shea D., Gunn I., Beak S. A., Edwards C. M., Meeran K., Choi S. J., Taylor G. M., Heath M. M., Lambert P. D., Wilding J. P., Smith D. M., Ghatei M. A., Herbert J., Bloom S. R. A role for glucagon-like peptide-1 in the central regulation of feeding. Nature. 379:1996;69-72.
32. Welch I., Saunders K., Read N. W. Effect of ileal and intravenous infusions of fat emulsions on feeding and satiety in human volunteers. Gastroenterology. 89:1985;1293-1297.
33. Tang-Christensen M., Vrang N., Larsen P. J. Glucagon-like peptide-1 (7-36) amide's central inhibition of feeding and peripheral inhibition of drinking are abolished by neonatal monosodium glutamate treatment. Diabetes. 47:1998;530-537.
34. van Dijk G., Thiele T. E., Donahey J. C. K., Campfield L. A., Smith F. J., Burn P., Bernstein I. L., Woods S. C., Seeley R. J. Central infusions of leptin and GLP-1-(7-36) amide differentially stimulate c-FLI in the rat brain. Am J Physiol. 271:1996;R1096-R1100.
35. Larsen P. J., Tang-Christensen M., Jessop D. S. Central administration of glucagon-like peptide-1 activates hypothalamic neuroendocrine neurons in the rat. Endocrinology. 138:1997;4445-4455.
36. Rowland N. E., Crews E. C., Gentry R. M. Comparison of Fos induced in rat brain by GLP-1 and amylin. Regul Pept. 71:1997;171-174.
37. van Dijk G., Thiele T. E., Seeley R. J., Woods S. C. Effect of central GLP-1-(7-36) amide and CCK-8 on satiety, taste aversion, and c-fos expression in rats. Soc Neurosci Abstr. 23:1997;575.
38. Li B. H., Rowland N. E. Cholecystokinin- and dexfenfluramine-induced anorexia compared using devazepide and c-fos expression in the rat brain. Regul Pept. 50:1994;223-233.
39. West D. B., Fey S. C., Woods S. C. Cholecystokinin persistently suppresses meal size but not food intake in free-feeding rats. Am J Physiol. 246:1984;R776-R787.
40. Donahey J. C. K., van Dijk G., Woods S. C., Seeley R. J. Intraventricular GLP-1 reduces short- but not long-term food intake or body weight in lean and obese rats. Brain Res. 779:1998;75-83.
41. Davis H. R. Jr, Mullins D. E., Pines J. M., Hoos L. M., France C. F., Compton D. S., Graziano M. P., Sybertz E. J., Strader C. D., van Heek M. Effect of chronic central administration of glucagon-like peptide-1 (7-36) amide on food consumption and body weight in normal and obese rats. Obes Res. 6:1998;147-156.
42. Meeran K., O'Shea D., Edwards C. M., Turton M. D., Heath M. M., Gunn I., Abusnana S., Rossi M., Small C. J., Goldstone A. P., Taylor G. M., Sunter D., Steere J Choi S. J., Ghatei M. A., Bloom S. R. Repeated intracerebroventricular administration of glucagon-like peptide-1 amide or exendin-(9-39) alters body weight in the rat. Endocrinology. 140:1999;244-250.
43. Woods S. C., Chavez M., Park C. R., Riedy C., Kaiyala K., Richardson R. D., Figlewicz D. P., Schwartz M. W., Porte D., Seeley R. J. The evaluation of insulin as a metabolic signal controlling behavior via the brain. Neurosci Biobehav Rev. 58:1995;1237-1241.
44. Campfield L. A., Smith F. J., Burn P. The OB protein (leptin) pathway - a link between adipose tissue mass and central neural networks. Horm Metab Res. 28:1996;619-632.
45. Woods S. C., Seeley R. J., Porte D., Schwartz M. W. Signals that regulate food intake and energy homeostasis. Science. 280:1998;1378-1383.
46. Goldstone A. P., Mercer J. G., Gunn I., Moar K. M., Edwards C. M. B., Rossi M., Howard J. K., Rasheed S., Turton M. D., Small C., Heath M. M., O'Shea D., Steere J., Meeran K., Ghatei M A Hoggard N., Bloom S. R. Leptin interacts with glucagon-like peptide-1 neurons to reduce food intake and body weight in rodents. FEBS Lett. 415:1997;134-138.
47. Maggio C. A., Haraczkiewicz E., Vasselli J. R. Diet composition alters the satiety effect of cholcystokinin in lean and obese Zucker rats. Physiol Behav. 43:1988;485-491.
48. Matson C. A., Ritter R. C. Long-term CCK-leptin synergy suggests a role for CCK in the regulation of body weight. Am J Physiol. 276:1999;R1038-R1045.
49. Moran T. H., Katz L. F., Plata-Salaman C. R., Schwartz G. J. Disordered food intake and obesity in rats lacking cholecystokinin A receptors. Am J Physiol. 274:1998;R618-R625.
50. Deutsch J. A. Food intake. Striker E. M. Handbook of Behavioral Neurobiology: Neurobiology of Food and Fluid Intake. 1990;151-182 Plenum Press, New York.
51. Thiele T. E., Roitman M. F., Bernstein I. L. c-Fos induction in rat brainstem in response to ethanol- and lithium chloride-induced conditioned taste aversions. Alcohol Clin Exp Res. 20:1996;1023-1028.
52. Smith J. C., Roll D. L. Trace conditioning with X-rays as an aversive stimulus. Psychonom Sci. 9:1965;11-12.
53. Seeley R. J., van Dijk G., Campfield L. A., Smith F. J., Nelligan J. A., Bell S. M., Baskin D. G., Woods S. C., Schwartz M. W. The effects of intraventricular administration of leptin on food intake and body weight in the rat. Horm Metab Res. 28:1996;664-668.
54. Thiele T. E., van Dijk G., Campfield L. A., Smith F. J., Burn P., Woods S. C., Bernstein I. L., Seeley R. J. Central infusion of GLP-1, but not leptin, produces conditioned taste aversions in rats. Am J Physiol. 272:1997;R726-R730.
55. van Dijk G., Thiele T. E., Seeley R. J., Woods S. C., Bernstein I. L. Glucagon-like peptide-1 and satiety. Nature. 385:1997;214.
56. McCutcheon B., Ballard M., McCaffrey R. J. Intraperitoneally injected cholecystokinin-octapeptide activates pica in rats. Physiol Behav. 51:1992;543-547.
57. Scalera G., Grigson P. S., Norgren R. Gustatory functions, sodium appetite, and conditioned taste aversion survives excitotoxic lesions of the thalamic taste area. Behav Neurosci. 111:1997;633-645.
58. Madden L. J., Brot M. D., Woods S. C., Seeley R. J. Central infusion of glucagon-like peptide 1 produces pica behavior in rats. Soc Neurosci Abstr. 23:1997;1075.
59. Asarian L., Corp E. S., Hrupka B., Geary N. Intracerebroventricular glucagon-like peptide-1 (7-36) amide inhibits sham feeding in rats without eliciting satiety. Physiol Behav. 64:1998;367-372.
60. Bures J., Buresova O., Ivanova S. F. Brain stem mechanisms of conditioned taste aversion learning in rats. Arch Int Physiol Biochem Biophys. 99:1991;A131-A134.
61. Kiefer S. W. Neural mediation of conditioned food aversions. Ann N Y Acad Sci. 433:1985;100-109.
62. Thiele T. E., Seeley R. J., D'Alessio D. A., Eng J., Bernstein I. L., Woods S. C., van Dijk G. Central infusion of glucagon-like peptide-1-(7-36) amide (GLP-1) receptor antagonist attenuates lithium chloride-induced c-Fos induction in rat brainstem. Brain Res. 801:1998;164-170.
63. Rinaman L. Interoceptive stress activates hindbrain neurons that contain glucagon-like peptide (GLP-1) and project to the PVN. The Physiologist. 41:1998;378.
64. Garcia J., Koelling R. A. Relation of cue to consequence in avoidance learning. Psychonom Sci. 4:1966;123-124.
65. McMahon L. R., Wellman P. J. PVN infusion of GLP-1-(7-36) amide suppresses feeding but does not induce aversion or alter locomotion in rats. Am J Physiol. 274:1998;R23-R29.
66. Ervin G. N., Birkemo L. S., Johnson M. F., Conger L. K., Mosher J. T., Menius J. A. The effects of anorectic and aversive agents on deprivation-induced feeding and taste aversion conditioning in rats. J Pharmacol Exp Therap. 273:1995;1203-1210.
67. Besterman H. S., Bloom S. R., Sarson D. L., Blackburn A. M., Johnston D. I., Patel H. R., Stewart J. S., Modigliani R., Guerin S. Gut-hormone profile in coeliac disease. Lancet. 1:1978;785-788.
68. Nauck M. A. Is glucagon-like peptide 1 an incretin hormone? Diabetologia. 42:1995;373-379.